FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385548008: Ibritumomab tiuxetan (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1459727019 Ibritumomab tiuxetan (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1479753011 Ibritumomab tiuxetan en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1459727019 Ibritumomab tiuxetan (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1459727019 Ibritumomab tiuxetan (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1479753011 Ibritumomab tiuxetan en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1479753011 Ibritumomab tiuxetan en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
931821000195111 ibritumomab tiuxetan it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
672341000274119 Ibritumomab-Tiuxetan de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
191661000077112 ibritumomab tiuxetan fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
817061000172113 ibritumomab tiuxétan fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
191661000077112 ibritumomab tiuxetan fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
817061000172113 ibritumomab tiuxétan fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
931821000195111 ibritumomab tiuxetan it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
672341000274119 Ibritumomab-Tiuxetan de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ibritumomab tiuxetan (substance) Is a agent d'anticorps monoclonal false Inferred relationship Existential restriction modifier (core metadata concept)
Ibritumomab tiuxetan (substance) Is a Immunosuppressant (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Ibritumomab tiuxetan (substance) Is a Antineoplastic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Ibritumomab tiuxetan (substance) Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing ibritumomab tiuxetan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ibritumomab tiuxetan (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Ibritumomab tiuxetan 3.2mg injection solution 2mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ibritumomab tiuxetan (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Ibritumomab tiuxetan The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ibritumomab tiuxetan (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Ibritumomab tiuxetan 1.6mg/mL radiopharmaceutical infusion kit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ibritumomab tiuxetan (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Injection of indium 111 and ibritumomab tiuxetan Direct substance True Ibritumomab tiuxetan (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing only ibritumomab tiuxetan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ibritumomab tiuxetan (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start